Shimada Shu

シマダシュウ | Shimada Shu

Affiliation and department：
Job title： Assistant professor

Research field (1)： Tumor biology

Research theme for competitive and other funds (12)：

2022 - 2025 正常免疫マウス腫瘍モデルを応用したヒトスキルス胃がんに対する複合免疫療法の開発
2022 - 2025 Establishment of detection technique for schirrous stomach cancer and estimation technique for progress degree in early stomach cancer using circulalry polarized light scattering
2020 - 2023 Envolvement of abnormal of SETDB-related histone modification enzyme and tumor immune environment in gastrointestinal cancer
2020 - 2022 Application of multiplex genome editing technology to the development of CAR-T therapy for refractory cancer subtypes
2019 - 2022 Clarification of diversity mechanisms for innovation of refractory cancer treatment

Show all

Papers (2)：

梅村謙太郎, 秋山好光, 島田周, 羽多野恵, 安川紘矢, 蒲池厚志, 田邉稔, 田中真二. 膵癌の新規エピゲノム異常の解明と標的治療の開発. 日本消化器外科学会雑誌. 2023. 56. Suppl.2. 545-545
安川紘矢, 島田周, 秋山好光, 田中真二. 肝癌における免疫治療抵抗性の解明乳酸代謝からみた新規治療法への展開(Elucidation of immunotherapy resistance in hepatocellular carcinoma: Novel treatment based on lactate metabolism). 日本癌学会総会記事. 2023. 82回. 1147-1147

MISC (2)：

梅村謙太郎, 梅村謙太郎, 秋山好光, 島田周, 羽多野恵, 安川紘矢, 安川紘矢, 蒲池厚志, 蒲池厚志, 田邉稔, et al. 膵癌の新規エピゲノム異常の解明と標的治療の開発. 日本消化器外科学会雑誌(Web). 2023. 56. Supplement2
安川紘矢, 安川紘矢, 島田周, 秋山好光, 田中真二. Elucidation of immunotherapy resistance in hepatocellular carcinoma: Novel treatment based on lactate metabolism. 日本癌学会学術総会抄録集(Web). 2023. 82nd

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page